Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Lung cancer Patients' fitness tracked during therapy in new study

NCT ID NCT07529145

Knowledge-focused Sponsor: Medical University of Bialystok Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at how lung cancer and its treatment affect patients' physical fitness. About 90 adults with lung cancer will take a special exercise test before and after starting treatment to measure how well their heart, lungs, and muscles work during exercise. The goal is to find patients who may have trouble tolerating treatment and help doctors personalize care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 90 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jan 2026

Expected to finish

Sep 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Adult patients (≥18 years) with histologically confirmed lung cancer (any stage) and WHO/ECOG performance status 0-2, treated with standard oncological management in a tertiary university hospital and undergoing cardiopulmonary exercise testing before treatment initiation and after the early phase of therapy or surgery.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age ≥ 18 years * Histologically confirmed lung cancer (any stage) * Qualified for standard oncological management (surgery and/or systemic therapy) * WHO/ECOG performance status 0-2 * Ability to perform cardiopulmonary exercise testing (CPET) * Written informed consent Exclusion Criteria: * Unstable ischemic heart disease * Symptomatic cardiac arrhythmias * Myocarditis or pericarditis * Decompensated heart failure * Active deep vein thrombosis * Suspected aortic dissection or severe aortic stenosis * Poorly controlled asthma * Resting oxygen saturation ≤ 85% on room air * Clinically relevant treatment-related adverse events above mild intensity (as applicable) * Any medical condition that, in the investigator's opinion, precludes safe participation in CPET * Withdrawal of informed consent

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Non-small cell carcinoma of lung are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

non-small cell lung carcinoma small cell lung carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Non-small cell carcinoma of lung Small cell carcinoma of lung

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • University Clinical Hospital in Bialystok, II Department of Pulmonology, Lung Cancer and Internal Medicine, Medical University of Bialystok

    RECRUITING

    Bialystok, Podlaskie Voivodeship, 15-276, Poland

More trials for these conditions

Other studies related to the condition(s) this trial covers.